What is β₂-Microglobulin?
β₂-Microglobulin (B2M) is a low–molecular-weight protein (~11.8 kDa) that forms the light chain of MHC Class I molecules present on all nucleated cells.
Constantly shed into blood
Freely filtered by glomeruli
Almost completely reabsorbed and catabolized in proximal tubules
Normal Reference Range
- Serum: ~0.7–1.8 mg/L
- Urine: < 300 µg/day
(Ranges vary slightly by lab)
1️⃣ Marker of Renal Function
A. Glomerular Dysfunction
↑ Serum B2M occurs when:
- Reduced GFR
- Chronic kidney disease (CKD)
- Acute kidney injury
Because it is filtered by the kidney, impaired filtration increases blood levels.
B. Tubular Dysfunction
↑ Urinary B2M occurs in:
- Proximal tubular damage
- Drug-induced nephrotoxicity
- Heavy metal toxicity
- Tubulointerstitial nephritis
Since it is normally reabsorbed in proximal tubules, tubular injury increases urinary excretion.
2️⃣ Hematological Malignancies
Serum B2M is an important tumor marker and prognostic indicator in:
- Multiple Myeloma
- Chronic Lymphocytic Leukemia
- Non-Hodgkin Lymphoma
Clinical importance:
- Reflects tumor burden
- Used in staging and prognosis
- Higher levels → poorer prognosis
In Multiple Myeloma, it is part of the International Staging System (ISS).
3️⃣ Inflammatory & Autoimmune Disorders
Levels may increase in:
- Rheumatoid arthritis
- Systemic lupus erythematosus
- Chronic infections (e.g., HIV)
Reason:
- Increased cell turnover
- Immune activation
4️⃣ Dialysis-Related Amyloidosis
Long-term dialysis patients may develop:
- β₂-microglobulin amyloid deposition
- Joint pain and carpal tunnel syndrome
Occurs due to inadequate clearance during dialysis.